Corbus Pharmaceuticals Holdings, Inc. (CRBP)
4.22
0.00 (0.00%)
USD |
NASDAQ |
Oct 30, 16:00
4.23
+0.01
(+0.24%)
After-Hours: 20:00
Corbus Pharmaceuticals Holdings Free Cash Flow : -86.69M for June 30, 2026
Free Cash Flow Chart
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| June 30, 2026 | -86.69M |
| March 31, 2026 | -73.65M |
| December 31, 2025 | -64.50M |
| September 30, 2025 | -59.51M |
| June 30, 2025 | -57.90M |
| March 31, 2025 | -50.25M |
| December 31, 2024 | -41.79M |
| September 30, 2024 | -36.86M |
| June 30, 2024 | -30.10M |
| March 31, 2024 | -28.95M |
| December 31, 2023 | -36.10M |
| September 30, 2023 | -37.55M |
| June 30, 2023 | -37.62M |
| March 31, 2023 | -42.04M |
| December 31, 2022 | -37.56M |
| September 30, 2022 | -39.86M |
| June 30, 2022 | -31.76M |
| March 31, 2022 | -37.06M |
| December 31, 2021 | -48.24M |
| September 30, 2021 | -56.65M |
| June 30, 2021 | -84.82M |
| March 31, 2021 | -93.91M |
| December 31, 2020 | -100.17M |
| Date | Value |
|---|---|
| September 30, 2020 | -105.85M |
| June 30, 2020 | -96.82M |
| March 31, 2020 | -86.77M |
| December 31, 2019 | -48.46M |
| September 30, 2019 | -38.92M |
| June 30, 2019 | -29.60M |
| March 31, 2019 | -19.25M |
| December 31, 2018 | -32.37M |
| September 30, 2018 | -27.75M |
| June 30, 2018 | -25.17M |
| March 31, 2018 | -24.70M |
| December 31, 2017 | -28.50M |
| September 30, 2017 | -24.38M |
| June 30, 2017 | -21.13M |
| March 31, 2017 | -18.02M |
| December 31, 2016 | -13.92M |
| September 30, 2016 | -9.324M |
| June 30, 2016 | -8.691M |
| March 31, 2016 | -6.037M |
| December 31, 2015 | -4.739M |
| September 30, 2015 | -5.086M |
| June 30, 2015 | -3.219M |
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Heron Therapeutics, Inc. | -12.14M |
| Tonix Pharmaceuticals Holding Corp. | -160.40M |
| Karyopharm Therapeutics, Inc. | -65.35M |
| Minerva Neurosciences, Inc. | -26.17M |
| Ocugen, Inc. | -61.02M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -29.63M |
| Cash from Investing (Quarterly) | 18.26M |
| Cash from Financing (Quarterly) | 9.075M |
| Free Cash Flow Per Share (Quarterly) | -1.527 |
| Free Cash Flow to Equity (Quarterly) | -32.69M |
| Free Cash Flow to Firm (Quarterly) | -29.63M |
| Free Cash Flow Yield | -122.8% |